» Authors » Masaharu Shinkai

Masaharu Shinkai

Explore the profile of Masaharu Shinkai including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 101
Citations 890
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Atsuta R, Fujii H, Hara Y, Tanaka H, Nakamura K, Obase Y, et al.
Respir Investig . 2024 Dec; 63(1):156-162. PMID: 39708411
Background: No previous studies have compared respiratory clinics and respiratory specialized facilities regarding causative diseases for bloody sputum and hemoptysis in Japan. Methods: We retrospectively compared causative diseases for bloody...
2.
Takeuchi Y, Ishikawa E, Sato T, Shinkai M, Takahashi Y, Lu X, et al.
Int Immunol . 2024 Dec; PMID: 39665863
The pandemic outbreak of SARS-CoV-2 has threatened human health worldwide. Among protective immune reactions, T cell responses are diverse among individuals, which is related to the differences in severity. A...
3.
Takahashi H, Morikawa M, Satake Y, Nagamatsu H, Hirose R, Yamada Y, et al.
Int J Infect Dis . 2024 Sep; 149:107244. PMID: 39313111
Objectives: Pharyngeal follicles similar to those seen in influenza have been observed in patients with coronavirus disease 2019 (COVID-19), suggesting their potential as early-stage diagnostic markers. In this study, we...
4.
Kotaki R, Moriyama S, Oishi S, Onodera T, Adachi Y, Sasaki E, et al.
Sci Transl Med . 2024 Aug; 16(761):eadp9927. PMID: 39167666
Immunological imprinting by ancestral SARS-CoV-2 strains is thought to impede the robust induction of Omicron-specific humoral responses by Omicron-based booster vaccines. Here, we analyzed the specificity and neutralization activity of...
5.
Kamiya Y, Shinoda M, Ishii N, Yamamoto S, Sekine T, Morikawa M, et al.
JGH Open . 2024 Aug; 8(8):e70004. PMID: 39130093
Background And Aim: Increased liver fibrosis scores (LFS), such as fibrosis-4 index (FIB-4) or non-alcoholic fatty liver disease fibrosis score (NFS), and fatty liver are known risk factors for severe...
6.
Shimada N, Sugawa S, Murakami S, Shinoda M, Ota S, Morikawa M, et al.
Vaccine X . 2024 Jul; 19:100518. PMID: 39040888
Background: Our investigation focused whether infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) before or after receiving the mRNA COVID-19 vaccine can increase immune protection. And we also investigated...
7.
Matsuo K, Takahashi H, Nagamatsu H, Hirose R, Yamada Y, Takei H, et al.
Int J Cardiol Cardiovasc Risk Prev . 2024 Jul; 22:200301. PMID: 38983608
Background: Nonepisodic angioedema with eosinophilia (NEAE) is a condition marked by angioedema and significant eosinophilia and often linked with atopic dermatitis. It predominantly affects young Asian women and occurs more...
8.
Shinkai M, Ota S, Ishikawa N, Tanimoto T, Suzuki H, Abe S, et al.
Respir Investig . 2024 Jun; 62(4):717-725. PMID: 38823191
Background: Respiratory syncytial virus (RSV), human metapneumovirus (hMPV), and influenza virus are responsible for acute respiratory tract infections (ARTIs) in adults. We assessed the clinical burden of RSV, hMPV and...
9.
Kamata H, Takamatsu K, Fukunaga K, Chubachi S, Nakagawara K, Namkoong H, et al.
Respir Investig . 2024 Apr; 62(4):572-579. PMID: 38669898
Background: No comprehensive analysis of the pulmonary sequelae of coronavirus disease 2019 (COVID-19) in Japan based on respiratory function tests and chest computed tomography (CT) has been reported. We evaluated...
10.
Fujii H, Hara Y, Obase Y, Haranaga S, Takahashi H, Shinkai M, et al.
Respir Investig . 2024 Mar; 62(3):395-401. PMID: 38484503
Background: The Guidelines for the Management of Cough and Sputum (2019) of the Japanese Respiratory Society (JRS) were the first internationally published guidelines for the management of sputum. However, the...